Genomma Lab InternacionalB. De C.v.
(OTC) GNMLF
Genomma Lab InternacionalB. De C.v. Financials at a Glance
Market Cap
$1.00B
Revenue (TTM)
$9.34B
Net Income (TTM)
$971.16M
EPS (TTM)
$0.09
P/E Ratio
11.70
Dividend
$0.03
Beta (Volatility)
0.08 (Low)
Dividend
$0.03
Beta (Volatility)
0.08 (Low)
Price
$1.00
Volume
50
Open
$1.00
Price
$1.00
Volume
50
Open
$1.00
Previous Close
$1.00
Daily Range
$1.00 - $1.00
52-Week Range
$0.93 - $1.43
Dividend
$0.03
Beta (Volatility)
0.08 (Low)
Price
$1.00
Volume
50
Open
$1.00
Previous Close
$1.00
Daily Range
$1.00 - $1.00
52-Week Range
$0.93 - $1.43
GNMLF News
GNMLF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genomma Lab InternacionalB. De C.v.
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,465
CEO
Marco Sparvieri
Website
www.genommalab.comHeadquarters
Mexico City, DF 01210, MX
GNMLF Financials
Key Financial Metrics (TTM)
Gross Margin
63%
Operating Margin
21%
Net Income Margin
9%
Return on Equity
15%
Return on Capital
23%
Return on Assets
7%
Earnings Yield
8.55%
Dividend Yield
0.03%
Payout Ratio
34.85%
Stock Overview
Market Cap
$1.00B
Shares Outstanding
1.00B
Volume
50
Short Interest
0.00%
Avg. Volume
2.74K
Financials (TTM)
Gross Profit
$611.40M
Operating Income
$206.90M
EBITDA
$227.93M
Operating Cash Flow
$76.94M
Capital Expenditure
$30.39M
Free Cash Flow
$46.55M
Cash & ST Invst.
$158.62M
Total Debt
$424.54M
Genomma Lab InternacionalB. De C.v. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$222.82M
-95.2%
Gross Profit
$135.86M
-95.4%
Gross Margin
60.97%
N/A
Market Cap
$1.00B
N/A
Market Cap/Employee
$623.05K
N/A
Employees
1,605
N/A
Net Income
$17.73M
-96.3%
EBITDA
$58.31M
-94.0%
Quarterly Fundamentals
Net Cash
$265.92M
-112.9%
Accounts Receivable
$397.46M
+86.5%
Inventory
$135.11M
+29.5%
Long Term Debt
$267.47M
+9.1%
Short Term Debt
$157.07M
+138.2%
Return on Assets
6.91%
N/A
Return on Invested Capital
22.92%
N/A
Free Cash Flow
$48.00M
-95.8%
Operating Cash Flow
$60.46M
-95.2%